Atlantis suprastructures

K193064 · Dentsply Sirona, Inc. · NHA · Mar 3, 2020 · Dental

Device Facts

Record IDK193064
Device NameAtlantis suprastructures
ApplicantDentsply Sirona, Inc.
Product CodeNHA · Dental
Decision DateMar 3, 2020
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3630
Device ClassClass 2
AttributesTherapeutic

Intended Use

Atlantis® suprastructures are indicated for attachment to dental implants or abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function. Atlantis® suprastructures are intended for attachment to a minimum of two (2) implants. The Atlantis® suprastructures are compatible with the implants and abutments listed in the Atlantis® Suprastructures Compatibility Chart:

Device Story

Atlantis suprastructures are patient-specific dental prosthetics (Bar, Bridge, Hybrid, 2-in-1) designed via CAD from patient dental models per clinician prescription. Fabricated via milling (CPTi or CoCr alloy) or additive manufacturing (titanium or CoCr alloy powder). Used in dental clinics; operated by dental technicians and clinicians. Output is a customized suprastructure attached to implants/abutments to restore chewing function. Device includes optional mechanical retention (pin/cell) and uses standard or Angulated Screw Access (ASA) fixation screws. Healthcare providers use the device to provide stable, implant-supported restorations for edentulous patients.

Clinical Evidence

No clinical data included. Substantial equivalence supported by bench testing: cross-sectional material analysis of interfaces, geometric measurement data, statistical compatibility analysis of OEM components, and reference to previously validated fatigue testing (ISO 14801), sterilization (ISO 17665), and biocompatibility data.

Technological Characteristics

Materials: CPTi (ASTM F67), CoCr alloy (ISO 22674), Ti-6Al-4V ELI (ASTM F136). Fabrication: CAD/CAM milling or additive manufacturing (powder bed). Design types: Bar, Bridge, Hybrid, 2-in-1. Fixation: Standard or Angulated Screw Access (ASA) screws. Sterilization: Moist heat (ISO 17665).

Indications for Use

Indicated for attachment to dental implants or abutments in patients with partially or totally edentulous jaws to restore chewing function. Requires attachment to a minimum of two implants. Compatible with specific implant/abutment systems listed in the device compatibility chart.

Regulatory Classification

Identification

An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.

Special Controls

*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA text logo on the right. The text logo has the FDA acronym in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue. March 3, 2020 Dentsply Sirona Inc. Karl Nittinger Vice President Corporate Regulatory Affairs 221 West Philadelphia Street, Suite 60W York, Pennsylvania 17401 Re: K193064 Trade/Device Name: Atlantis® suprastructures Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: Class II Product Code: NHA Dated: December 3, 2019 Received: December 4, 2019 Dear Karl Nittinger: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely. for Srinivas Nandkumar, Ph.D. Director DHT1B: Division of Dental Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K193064 Device Name Atlantis® suprastructures Indications for Use (Describe) Atlantis® suprastructures are indicated for attachment to dental implants or abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function. Atlantis® suprastructures are intended for attachment to a minimum of two (2) implants. Atlantis® suprastructures are compatible with following implants and abutments: | Manufacturer/ | Implant system | |--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | BioHorizons | Implant Level<br>Internal/ Tapered 3.5, 4.5, 5.7<br>Abutment Level<br>Multi-unit abutment | | Biomet 3i | Implant Level<br>Certain™ 3.25, 4.0, 4/3, 5.0, 5/4, 6.0<br>Certain™ Prevail™ 3/4/3 (3.4), 4/5/4, 5/6/5, 4/3, 5/4, 6/5<br>Certain™ XP 4/5, 5/6<br>Abutment Level<br>Low Profile Abutment | | Camlog | Implant Level<br>Screw-line Implant 3.3<br>Screw-line/Root-line Implant 3.8, 4.3<br>Screw-line/Root-line Implant 5.0, 6.0 | | Dentsply<br>Sirona | Implant Level<br>Astra Tech Implant System®<br>Astra Tech Implant EV 3.0 – Green<br>Astra Tech Implant EV 3.6 – Purple<br>Astra Tech Implant EV 4.2 – Yellow<br>Astra Tech Implant EV 4.8 – Blue<br>Astra Tech Implant EV 5.4 – Brown<br>Astra Tech Implant EV Profile 4.2<br>Astra Tech Implant EV Profile 4.8<br>OsseoSpeed® TX 3.0 – Yellow<br>OsseoSpeed® TX 3.5, 4.0 – Aqua<br>OsseoSpeed® TX 4.5, 5.0 – Lilac<br>OsseoSpeed® TX Profile 4.5/5.0<br>Xive®<br>Xive® S 3.0<br>Xive® S 3.4, 3.8, 4.5, 5.5<br>Abutment Level<br>Astra Tech Implant System®<br>UniAbutment EV<br>Angled Abutment EV<br>Multibase Abutment EV<br>20° UniAbutment<br>45° Uni Abutment<br>Angled Abutment 20°<br>Ankylos®<br>Ankylos® Balance Base Narrow D4.2<br>Ankylos® Balance Base D5.5 | | | Xive® | | | Xive® TG 3.4, 3.8, 4.5 | | | Xive® MP 3.4, 3.8, 4.5 | | | Xive® MP 5.5 | | Keystone | Implant Level | | | PrimaConnex SD 3.3, 3.5 | | | PrimaConnex RD 4.0, 4.1 | | | PrimaConnex WD 5.0 | | | Genesis 3.8, 4.5, 5.5, 6.5 | | MIS | Implant Level | | | Internal Hex Narrow SEVEN – M4 | | | Internal Hex Standard SEVEN – M4 | | | Internal Hex Wide SEVEN – M4 | | | Conical Connection Narrow C1 - V3 | | | Conical Connection Standard C1 - V3 | | | Conical Connection Wide C1 | | | Abutment Level | | | Multi-Unit Abutment | | Nobel Biocare | Implant Level | | | NobelActive NP 3.5 | | | NobelActive RP 4.3, 5.0 | | | NobelActive WP 5.5 | | | NobelReplace NP 3.5 | | | NobelReplace RP 4.3 | | | NobelReplace WP 5.0 | | | NobelReplace 6.0 | | | Branemark System NP 3.3 | | | Branemark System RP 3.75, 4.0 | | | Abutment Level | | | Multi-Unit Abutment RP | | Straumann | Implant Level | | | Bone Level 3.3 NC | | | Bone Level 4.1, 4.8 RC | | | Standard/Standard Plus 4.8 RN (Regular Neck) | | | Standard/Standard Plus 4.8 WN (Wide Neck) | | | Abutment Level | | | RN Abutment Level | | | WN Abutment Level | | | Bone Level Multi-Base Abutment D3.5, 4.5 | | | Bone Level Multi-Base Angled Abutment | | | Screw-Retained Abutment 3.5 | | | Screw-Retained Abutment 4.6 | | Zimmer Dental | Implant Level | | | Tapered Screw-Vent™ 3.5, 4.5, 5.7 | | | Screw Vent™ 3.3, 3.7, 4.5 | | | Abutment Level | | | Tapered Abutment | {3}------------------------------------------------ {4}------------------------------------------------ Type of Use (Select one or both, as applicable) | X | Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) ### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." FORM FDA 3881 (8/14) PSC Publishing Services (301) 443-6740 вн {5}------------------------------------------------ Dentsply Sirona 221 West Philadelphia Street Suite 60W York, PA 17401 Image /page/5/Picture/1 description: The image shows the logo for Dentsply Sirona. The logo consists of a stylized, abstract shape on the left, resembling a curved leaf or a stylized letter 'S'. To the right of the shape are the words "Dentsply" on the top line and "Sirona" on the bottom line, with both words in a simple, sans-serif font. The color of the logo and text is a muted gray. ## 510(k) SUMMARY For K193064 Atlantis® suprastructures #### 1. Submitter Information: Dentsply Sirona Inc. 221 West Philadelphia Street Suite 60W York, PA 17401 | Contact Person: | Karl Nittinger | |-------------------|-----------------------------------| | Telephone Number: | 717-849-4424 | | Fax Number: | 717-849-4343 | | Email: | karl.nittinger@dentsplysirona.com | Date Prepared: 03 March 2020 #### 2. Device Name: - Proprietary Name: Atlantis® suprastructures . - Classification Name: Endosseous dental implant abutment . - CFR Number: 21 CFR 872.3630 - . Device Class: ● - Class II Product Code: NHA #### 3. Predicate Device: . ## Predicate Device for subject Atlantis suprastructures made by milling: | Predicate Device Name | 510(k) | Company Name | |---------------------------------------------------------|---------|-----------------| | Multibase Abutments EV and ATLANTIS™<br>Suprastructures | K163350 | Dentsply Sirona | ### Predicate Device for subject Atlantis suprastructures made by additive manufacturing: | Predicate Device Name | 510(k) | Company Name | |---------------------------|---------|-----------------| | ATLANTIS™ Suprastructures | K163398 | Dentsply Sirona | {6}------------------------------------------------ Reference Devices: | Reference Device Name | 510(k) | Company Name | |-------------------------------------------------------------------------------------------------------------------|---------|-----------------------------------------------------| | ATLANTIS™ ISUS Implant Suprastructures | K160207 | Dentsply Sirona | | BioHorizons Tapered Internal Implant System | K071638 | BioHorizons Implant Systems Inc. | | BioHorizons Simple Solutions with Laser-Lok® | K100985 | BioHorizons Implant Systems, Inc. | | MIS Internal Hex Dental Implant System | K180282 | MIS Implants Technologies Ltd.<br>(Dentsply Sirona) | | MIS C1 Narrow Platform Conical Connection<br>Implant System, MIS C1 Wide Platform Conical<br>Connection Abutments | K172505 | MIS Implants Technologies Ltd.<br>(Dentsply Sirona) | | MIS V3 Conical Connection Dental Implant<br>System | K163349 | MIS Implants Technologies Ltd.<br>(Dentsply Sirona) | | Conical Connection Implants | K112162 | MIS Implants Technologies Ltd.<br>(Dentsply Sirona) | | NobelActive Wide Platform (WP) | K133731 | Nobel Biocare AB | | Various Branemark System Dental Implant<br>Products | K022562 | Nobel Biocare AB | #### 4. Description of Device: Atlantis suprastructures are indicated for attachment to dental implants or abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function. The subject Atlantis suprastructures include new compatible interfaces of the currently marketed Atlantis suprastructures made by milling (K163350) or additive manufacturing techniques (K163398) for the following abutments and implants: - BioHorizons Multi-unit abutment MIS Internal Hex Narrow SEVEN - M4 MIS Internal Hex Standard SEVEN - M4 MIS Internal Hex Wide SEVEN - M4 MIS Conical Connection Narrow C1 - V3 MIS Conical Connection Standard C1 - V3 MIS Conical Connection Wide C1 MIS Multi-Unit Abutment Nobel Biocare NobelActive WP 5.5 Nobel Biocare Branemark System NP 3.3 Nobel Biocare Branemark System RP 3.75, 4.0 The design of the subject device is derived from patient dental models and completed by Dentsply Sirona technicians using computer-assisted design (CAD) according to the clinician's prescription. The final CAD design of the Atlantis suprastructures are fabricated using additive manufacturing (AM) to produce a customized, patient-specific device. The Atlantis suprastructures subject of this bundled premarket notification are fabricated by milling or by additive manufacturing techniques. {7}------------------------------------------------ The milled Atlantis suprastructures are composed of commercially pure titanium (CPTi) or cobalt chrome alloy and are available in following design types: Bar, Bridge, Hybrid and 2 in 1. Additional design limitations regarding minimum required segment cross-section, maximum span between implants and maximum cantilever extension, have been introduced for Atlantis suprastructures made by milling. Atlantis suprastructures made by additive manufacturing are provided as Bridge and Hybrid types with optional mechanical retention (pin or cell retention) on the surface. The manufacturing of the Bridges and Hybrids of the Atlantis suprastructures by an additive manufacturing technique start from a titanium alloy and a cobalt-chrome alloy in powder form. Milled variants of the subject Atlantis® suprastructures are offered in versions composed of unalloyed titanium conforming to ASTM F67 (Standard Specification for Unalloyed Titanium for Surgical Implant Applications) and cobalt chromium alloy (CoCr) conforming to ISO 22674 (Dentistry – Metallic materials for fixed and removable restorations and appliances). Variants of the subject Atlantis® suprastructures which are fabricated utilizing additive manufacturing are manufactured using titanium alloy powder or cobalt chromium alloy powder conforming to ISO 22674 (Dentistrv – Metallic materials for fixed and removable restorations and appliances). Fixation screws for use with the subject Atlantis® suprastructures are composed of titanium alloy confirming to ASTM F136 (Standard Specification for Wrought Titanium-6 Aluminum-4 Vanadium ELI (Extra Low Interstitial) Alloy for Surgical Implant Applications). Screws are available for all compatible implants and abutments to screw the Atlantis suprastructures into the implant or onto the abutment. Labeling is modified by providing a separate compatibility chart which lists all implants and abutments compatible with the Atlantis suprastructures. #### న. Indications for Use: Atlantis® suprastructures are indicated for attachment to dental implants or abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring function. Atlantis® suprastructures are intended for attachment to a minimum of two (2) implants. Atlantis® suprastructures are compatible with the implants and abutments listed in the Atlantis® Suprastructures Compatibility Chart: {8}------------------------------------------------ | Manufacturer/ | Implant system | |--------------------|------------------------------------------------------------| | BioHorizons | Implant Level | | | Internal/ Tapered 3.5, 4.5, 5.7 | | | Abutment Level | | | Multi-unit abutment | | Biomet 3i | Implant Level | | | Certain™ 3.25, 4.0, 4/3, 5.0, 5/4, 6.0 | | | Certain™ Prevail™ 3/4/3 (3.4), 4/5/4, 5/6/5, 4/3, 5/4, 6/5 | | | Certain™ XP 4/5, 5/6 | | | Abutment Level | | | Low Profile Abutment | | Camlog | Implant Level | | | Screw-line Implant 3.3 | | | Screw-line/Root-line Implant 3.8, 4.3 | | | Screw-line/Root-line Implant 5.0, 6.0 | | Dentsply<br>Sirona | Implant Level | | | Astra Tech Implant System® | | | Astra Tech Implant EV 3.0 - Green | | | Astra Tech Implant EV 3.6 - Purple | | | Astra Tech Implant EV 4.2 - | | | Yellow Astra Tech Implant EV 4.8 | | | - Blue Astra Tech Implant EV 5.4 – | | | Brown Astra Tech Implant EV | | | Profile 4.2 Astra Tech Implant EV | | | Profile 4.8 OsseoSpeed® TX 3.0 – | | | Yellow OsseoSpeed® TX 3.5, 4.0 –<br>Aqua | | | OsseoSpeed® TX 4.5, 5.0 – Lilac | | | OsseoSpeed® TX Profile 4.5/5.0 | | | Xive® | | | Xive® S 3.0 | | | Abutment Level | | | Astra Tech Implant System® | | | UniAbutment EV | | | Angled Abutment EV | | | Multibase Abutment EV | | | 20° UniAbutment | | | 45° UniAbutment | | | Angled Abutment 20° | | | Ankylos® | | | Ankylos® Balance Base Narrow D4.2 | | | Ankylos® Balance Base D5.5 | | | Xive® | | | Xive® TG 3.4, 3.8, 4.5 | | | Xive® MP 3.4, 3.8, 4.5 | | | Xive® MP 5.5 | | Keystone | Implant Level | | | PrimaConnex SD 3.3, 3.5 | | | PrimaConnex RD 4.0, 4.1 | | | PrimaConnex WD 5.0 | | | Genesis 3.8, 4.5, 5.5, 6.5 | | MIS | Implant Level | | | Internal Hex Narrow SEVEN – M4 | | | Internal Hex Standard SEVEN - M4 | | | Internal Hex Wide SEVEN – M4 | | | Conical Connection Narrow C1 - V3 | | | Conical Connection Standard C1 - V3 | | | Conical Connection Wide C1 | | | Abutment Level | | | Multi-Unit Abutment | | Nobel Biocare | Implant Level | | | NobelActive NP 3.5 | | | NobelActive RP 4.3, 5.0 | | | NobelActive WP 5.5 | | | NobelReplace NP 3.5 | | | NobelReplace RP 4.3 | | | NobelReplace WP 5.0 | | | NobelReplace 6.0 | | | Branemark System NP 3.3 | | | Branemark System RP 3.75, 4.0 | | | Abutment Level | | | Multi-Unit Abutment RP | | Straumann | Implant Level | | | Bone Level 3.3 NC | | | Bone Level 4.1, 4.8 RC | | | Standard/Standard Plus 4.8 RN (Regular Neck) | | | Standard/Standard Plus 4.8 WN (Wide Neck) | | | Abutment Level | | | RN Abutment Level | | | WN Abutment Level | | | Bone Level Multi-Base Abutment D3.5, 4.5 | | | Bone Level Multi-Base Angled Abutment | | | Screw-Retained Abutment 3.5 | | | Screw-Retained Abutment 4.6 | | Zimmer Dental | Implant Level | | | Tapered Screw-Vent™ 3.5, 4.5, 5.7 | | | Screw Vent™ 3.3, 3.7, 4.5 | | | Abutment Level | | | Tapered Abutment | {9}------------------------------------------------ #### Substantial Equivalence: 6. An overview of the similarities and differences between the subject and predicate devices is given in Table 5.1 and 5.2 below. The indications for use of the subject and predicate Atlantis suprastructures (K163350, K163398) are identical with respect to the clinical indications. The indications for use of the subject and predicate devices only differ regarding the compatible implants and abutments which are added by this 510(k) premarket notification. Design types, material, manufacturing techniques (milling, additive manufacturing), screw types (standard screw, Angulated Screw Access (ASA) as well as mechanical retention methods on the suprastructure surface (cell, pin) of the subject Atlantis suprastructures are the same as cleared for the predicate Atlantis suprastructures made by milling {10}------------------------------------------------ (K163350) or additive manufacturing (K163398). The additional design limitations for some design types of milled Atlantis suprastructures (Non-Standard bar, 2 in1 primary structure, Hybrid, Bridge) are within the design parameters cleared for the predicate device (K163350). The design parameters cleared for the predicate Atlantis suprastructures made by additive manufacturing (K163398) remain unchanged for the subject device. #### 7. Non-Clinical Performance Data: Following non-clinical test data and analyses are included to support substantial equivalence: · Cross-sectional material analysis of the subject Atlantis suprastructure interfaces with the compatible implants and abutments, comparison to existing worst case interface geometry and reference to results of fatigue testing (K160207) conducted according to test methods of ISO 14801: Dental-implants Dynamic Fatigue Test for Endosseous Dental Implants. ISO 14801. · Geometric measurement data and statistical compatibility analysis of OEM implant bodies, OEM abutments, and OEM fixation screws, to support the compatibility of the subject Atlantis suprastructure interfaces with the compatible implants (K071638, K100985, K133731, K022562). · Reference to process validation testing (K163398) for Atlantis suprastructures made by additive manufacturing. · Reference by equivalence to validation of moist heat sterilization parameters conducted according to ISO 17665-1 Sterilization of health care products -- Moist heat -- Part 1: Requirements for the development, validation, and routine control of a sterilization process for medical devices and ISO17665-2 Sterilization of health care products - Moist heat - Part 2: Guidance on the application of ISO 17665-1. · Reference by equivalence to biocompatibility data of predicate devices (K163350, K163398). #### 8. Clinical Performance Data: No human clinical data was included in this premarket notification to support the substantial equivalence of the subject Atlantis suprastructures. #### 9. Conclusion Regarding Substantial Equivalence: The information included in this bundled 510(k) submission supports the substantial equivalence of the subject Atlantis suprastructures. The subject Atlantis suprastructures have the same intended use as the legally marketed predicate devices cleared under premarket notifications K163350 and K163398. The subject device also has similar indications for use and incorporates the same fundamental technology as the predicate devices (K163398). Results of technical analyses and compatibility studies to verify the performance of the subject Atlantis suprastructures support a determination of substantial equivalence. {11}------------------------------------------------ | Subject<br>Device | Indications for Use | | |------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------| | Dentsply<br>Sirona<br>Atlantis®<br>suprastructures | Atlantis® suprastructures are indicated for attachment to dental implants or abutments in the<br>treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.<br>Atlantis® suprastructures are intended for attachment to a minimum of two (2) implants.<br>The Atlantis® suprastructures are compatible with the implants and abutments listed in the<br>Atlantis® Suprastructures Compatibility Chart: | | | | | | | Manufacturer/<br>Company | Implant system | | | BioHorizons | Implant Level<br>Internal/ Tapered 3.5, 4.5, 5.7<br>Abutment Level<br>Multi-unit abutment | | | Biomet 3i | Implant Level<br>Certain™ 3.25, 4.0, 4/3, 5.0, 5/4, 6.0<br>Certain™ Prevail™ 3/4/3 (3.4), 4/5/4, 5/6/5, 4/3, 5/4, 6/5<br>Certain™ XP 4/5, 5/6<br>Abutment Level<br>Low Profile Abutment | | | Camlog | Implant Level<br>Screw-line Implant 3.3<br>Screw-line/Root-line Implant 3.8, 4.3<br>Screw-line/Root-line Implant 5.0, 6.0 | | | Dentsply Sirona | Implant Level<br>Astra Tech Implant System®<br>Astra Tech Implant EV 3.0 - Green<br>Astra Tech Implant EV 3.6 - Purple<br>Astra Tech Implant EV 4.2 – Yellow<br>Astra Tech Implant EV 4.8 – Blue<br>Astra Tech Implant EV 5.4 - Brown<br>Astra Tech Implant EV Profile 4.2<br>Astra Tech Implant EV Profile 4.8<br>OsseoSpeed® TX 3.0 – Yellow<br>OsseoSpeed® TX 3.5, 4.0 - Aqua<br>OsseoSpeed® TX 4.5, 5.0 - Lilac<br>OsseoSpeed® TX Profile 4.5/5.0<br>Xive®<br>Xive® S 3.0<br>Xive® S 3.4, 3.8, 4.5, 5.5<br>Abutment Level<br>Astra Tech Implant System®<br>UniAbutment EV<br>Angled Abutment EV<br>Multibase Abutment EV<br>20° UniAbutment<br>45° UniAbutment<br>Angled Abutment 20°<br>Ankylos®<br>Ankylos® Balance Base Narrow D4.2<br>Ankylos® Balance Base D5.5<br>Xive®<br>Xive® TG 3.4, 3.8, 4.5<br>Xive® MP 3.4, 3.8, 4.5<br>Xive® MP 5.5 | | | Subject<br>Device | Indications for Use | | | Keystone Dental | Implant Level<br>PrimaConnex SD 3.3, 3.5<br>PrimaConnex RD 4.0, 4.1<br>PrimaConnex WD 5.0<br>Genesis 3.8, 4.5, 5.5, 6.5 | | | MIS | Implant Level<br>Internal Hex Narrow SEVEN – M4<br>Internal Hex Standard SEVEN – M4<br>Internal Hex Wide SEVEN – M4<br>Conical Connection Narrow C1 - V3<br>Conical Connection Standard C1 - V3<br>Conical Connection Wide C1<br>Abutment Level<br>Multi-Unit Abutment | | | Nobel Biocare | Implant Level<br>NobelActive NP 3.5<br>NobelActive RP 4.3, 5.0<br>NobelActive WP 5.5<br>NobelReplace NP 3.5<br>NobelReplace RP 4.3<br>NobelReplace WP 5.0<br>NobelReplace 6.0<br>Branemark System NP 3.3<br>Branemark System RP 3.75, 4.0<br>Abutment Level<br>Multi-Unit Abutment RP | | | Straumann | Implant Level<br>Bone Level 3.3 NC<br>Bone Level 4.1, 4.8 RC<br>Standard/Standard Plus 4.8 RN (Regular Neck)<br>Standard/Standard Plus 4.8 WN (Wide Neck)<br>Abutment Level<br>RN Abutment Level<br>WN Abutment Level<br>Bone Level Multi-Base Abutment D3.5, 4.5<br>Bone Level Multi-Base Angled Abutment<br>Screw-Retained Abutment 3.5<br>Screw-Retained Abutment 4.6…
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%